ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
Symbol
QNRX
Shares outstanding
9,352,472 shares
Disclosed Ownership
934,312 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 16:54:47 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 10% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) on 31 Dec 2024."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:54.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 10% 934,312 0 934,312 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 10% 934,312 0 934,312 /s/ Steven Boyd Steven Boyd